Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Pharma

Partners Sam Glick and Sven-Olaf Vathje write in Harvard Business Review on how countries around the world can learn from a broken American healthcare system.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Duke Royalty Limited, a Guernsey-based public diversified royalty company, and Oliver Wyman announced this week a financing collaboration in the rapidly developing pharmaceutical and healthcare-related royalty market.

Partner, Health & Life Sciences, Oliver Wyman

This week in Guinea, reports Tim Irwin in UNICEF Connect, aid workers have been responding to Ebola by addressing rumors and resistance. The disease continues to present challenges around the globe.

Oliver Wyman Partner Suresh Kumar, former US Assistant Secretary of Commerce, spoke last week at the Institute of Medicine of the National Academies in Washington, DC, as part of the two-day workshop "Enabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases."

Oliver Wyman alum & Executive Vice President at Sanofi

An international panel of experts shared perspectives at the 2015 World Economic Forum annual meeting on what the world has learned from Africa’s Ebola epidemic.

Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

More than 60 attendees gathered at Oliver Wyman's breakfast briefing early Wednesday morning in Davos, Switzerland, during the World Economic Forum annual meeting.

Oliver Wyman’s “Responding to Ebola” briefing this week at the World Economic Forum in Davos, Switzerland, will feature a distinguished panel of experts both on the ground and leading global coordination.